Ultimovacs ASA (ULTI) Company Profile (Euronext EU): FKnol.com

Stock Screener for Euronext EU Stocks (Sector-wise)

Ultimovacs ASA, whose shares are listed on and trade on the Euronext EU stock exchange, has the following business profile:

Company's Full Name:	Ultimovacs ASA
Short Name:	Ultimovacs ASA
Trading Ticker Symbol:	ULTI
Primary Exchange(s):	Oslo Børs (Oslo Stock Exchange)
Exchange Code:	OSL
ISIN:	NO0010851603
Headquarter/Listing Location:	Oslo, Norway
Primary Industry Sector:	Healthcare
Secondary Sub-sector:	Members Only! Login / Register to view
Main Business Areas/Categories:	Members Only! Login / Register to view

Market and Trading Information for Ultimovacs ASA (Euronext EU)

The following details are available for trading and market data about the stock of Ultimovacs ASA as of writing. Currency is NOK.

Current Share Price:	NOK 122.80
Previous Year's Closing Price:	NOK 110.00
Percentage Price Change (YTD):	11.64%
Market Cap:	4.23 billion
52-week Price Range:	67.9 - 178.6
Dividend Per Share:	0
EPS (TTM):	-6
Price-Earnings (Trailing):	0
Price-Earnings (Forward):	10.93
Currency:	NOK

Company Profile and Business Description for Ultimovacs ASA

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for various cancers. The company engages in performing a clinical development program with clinical trials in Europe and the United States. Its lead product candidate is UV1, a peptide-based vaccine, which completed Phase I clinical trial that induces T cell response against the universal cancer antigen telomerase. The company was founded in 2011 and is headquartered in Oslo, Norway.